These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Amphotericin B potentiation of rifampicin as an antifungal agent against the yeast phase of Histoplasma capsulatum. Kobbayashi GS; Medoff G; Schlessinger D; Kwan CN; Musser WE Science; 1972 Aug; 177(4050):709-10. PubMed ID: 5054147 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the in vitro and in vivo activity of the bis-triazole derivative UK 49,858 with that of amphotericin B against Histoplasma capsulatum. Kobayashi GS; Travis S; Medoff G Antimicrob Agents Chemother; 1986 Apr; 29(4):660-2. PubMed ID: 3010852 [TBL] [Abstract][Full Text] [Related]
5. Rifampin Enhances the Activity of Amphotericin B against Fusarium solani Species Complex and Aspergillus flavus Species Complex Isolates from Keratitis Patients. He Y; Zhou L; Gao C; Han L; Xu Y Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115342 [TBL] [Abstract][Full Text] [Related]
6. Fungistatic and fungicidal effects of amphotericin B, ketoconazole and fluconazole (UK 49,858) against histoplasma capsulatum in vitro and in vivo. Polak A; Dixon DM Mykosen; 1987 Apr; 30(4):186-94. PubMed ID: 3035371 [No Abstract] [Full Text] [Related]
7. A proposal for antifungal epidemiological cut-off values against Histoplasma capsulatum var. capsulatum based on the susceptibility of isolates from HIV-infected patients with disseminated histoplasmosis in Northeast Brazil. Brilhante RSN; Guedes GMM; Silva MLQD; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG Int J Antimicrob Agents; 2018 Aug; 52(2):272-277. PubMed ID: 29592837 [TBL] [Abstract][Full Text] [Related]
8. Enhanced efficacy of amphotericin B and rifampicin combined in treatment of murine histoplasmosis and blastomycosis. Kitahara M; Kobayashi GS; Medoff G J Infect Dis; 1976 Jun; 133(6):663-8. PubMed ID: 932494 [TBL] [Abstract][Full Text] [Related]
9. Synergism of amphotericin B and 2-deoxyglucose against Histoplasma capsulatum yeasts in vitro. Berliner MD Microbios; 1975; 12(50):209-18. PubMed ID: 1160617 [TBL] [Abstract][Full Text] [Related]
10. Posaconazole enhances the activity of amphotericin B against Aspergillus hyphae in vitro. Perkhofer S; Lugger H; Dierich MP; Lass-Flörl C Antimicrob Agents Chemother; 2007 Feb; 51(2):791-3. PubMed ID: 17116665 [TBL] [Abstract][Full Text] [Related]
12. Rifampin: inhibition of ribonucleic acid synthesis after potentiation by amphotericin B in Saccharomyces cerevisiae. Battaner E; Kumar BV Antimicrob Agents Chemother; 1974 Apr; 5(4):371-6. PubMed ID: 15825390 [TBL] [Abstract][Full Text] [Related]
13. The in vitro effects of interferon-gamma, alone or in combination with amphotericin B, tested against the pathogenic fungi Candida albicans and Aspergillus fumigatus. El-Khoury M; Ligot R; Mahoney S; Stack CM; Perrone GG; Morton CO BMC Res Notes; 2017 Aug; 10(1):364. PubMed ID: 28764751 [TBL] [Abstract][Full Text] [Related]
14. Combined therapy with amphotericin B and caspofungin in an experimental model of disseminated histoplasmosis. Rodríguez-Arellanes G; Taylor ML; Pérez-Torres A; Curiel-Quesada E; Vargas-Mendoza CF; Martínez-Rivera MA Rev Invest Clin; 2009; 61(1):4-10. PubMed ID: 19507469 [TBL] [Abstract][Full Text] [Related]
16. Murine models of blastomycosis, coccidioidomycosis, and histoplasmosis. Sorensen KN; Clemons KV; Stevens DA Mycopathologia; 1999; 146(2):53-65. PubMed ID: 10822504 [TBL] [Abstract][Full Text] [Related]
17. Drug-induced alterations in the ultrastructural organization of Histoplasma capsulatum and Blastomyces dermatitidis. Lane JW; Garrison RG; Johnson DR Mycopathol Mycol Appl; 1972 Dec; 48(4):289-96. PubMed ID: 4119289 [No Abstract] [Full Text] [Related]
18. A9145, a new adenine-containing antifungal antibiotic. II. Biological activity. Gordee RS; Butler TF J Antibiot (Tokyo); 1973 Aug; 26(8):466-70. PubMed ID: 4600794 [No Abstract] [Full Text] [Related]